Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine
Under GSH-deficient conditions, treatment with siRNA (Fig
The DAC modification a reactive linker conjugated to a Lys residue enables the peptide to bind reversibly to serum albumin, slowing clearance
17 , 1498U207 (2011)
Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Busha AI: N-acetyl cysteine as a glutathione precursor for schizophreniaa double-blind, randomized, placebo-controlled trial